With HIV Management
Many HIV-treating clinicians were hoping that integrase strand transfer inhibitors (INSTIs) would offer fewer metabolic side effects than protease inhibitors (PIs) and non-nucleoside reverse transcriptase inhibitors (NNRTIs), but their link to weight gain has caused some concern.
There was hope “that INSTIs would rescue patients from some metabolic side effects,” said Jeffrey Laurence, MD, a professor of medicine at Weill Cornell Medical College, in